0001192482-15-000020.txt : 20150205
0001192482-15-000020.hdr.sgml : 20150205
20150205165801
ACCESSION NUMBER: 0001192482-15-000020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150204
FILED AS OF DATE: 20150205
DATE AS OF CHANGE: 20150205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spark Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609351
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462654405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 888-772-7560
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Children's Hospital of Philadelphia Foundation
CENTRAL INDEX KEY: 0001632060
STATE OF INCORPORATION: PA
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36819
FILM NUMBER: 15580878
BUSINESS ADDRESS:
STREET 1: 34TH STREET AND CIVIC CENTER BOULEVARD
CITY: PHILADELPHIA
STATE: PA
ZIP: 19004
BUSINESS PHONE: 267-426-6957
MAIL ADDRESS:
STREET 1: 34TH STREET AND CIVIC CENTER BOULEVARD
CITY: PHILADELPHIA
STATE: PA
ZIP: 19004
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-02-04
0001609351
Spark Therapeutics, Inc.
ONCE
0001632060
Children's Hospital of Philadelphia Foundation
3737 MARKET STREET
SUITE 1300
PHILADELPHIA
PA
19104
0
0
1
0
Common Stock
2015-02-04
4
C
0
1000000
A
5943629
D
Common Stock
2015-02-04
4
C
0
2795031
A
8738660
D
Common Stock
2015-02-04
4
C
0
61552
A
8800212
D
Common Stock
2015-02-04
4
P
0
100000
23.00
A
8900212
D
Series A Preferred Stock
2015-02-04
4
C
0
1000000
0
D
Common Stock
1000000
0
D
Series B Preferred Stock
2015-02-04
4
C
0
2795031
0
D
Common Stock
2795031
0
D
Accrued Preferred Stock Dividends
2015-02-04
4
C
0
61552
0
D
Common Stock
61552
0
D
Shares of Series A Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015.
Shares of Series B Preferred Stock automatically converted into shares of the Common Stock on a one-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering on February 4, 2015.
Paid-in-kind dividends declared and paid on the Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock on a one-for-one basis without payment of further consideration upon the closing of the issuer's initial public offering on February 4, 2015.
Jeffrey D. Kahn, Attorney-In-Fact for The Children's Hospital of Philadelphia Foundation
2015-02-04